Literature DB >> 22142503

Fetal counselling for surgical conditions.

Kokila Lakhoo1.   

Abstract

Foetal counselling is best achieved by a multidisciplinary team that can favourably influence the perinatal management of prenatally diagnosed anomalies and provide this information to prospective parents. Prenatal diagnosis has remarkably improved our understanding of surgically correctable congenital malformations. It has allowed us to influence the delivery of the baby, offer prenatal surgical management and discuss the options of termination of pregnancy for seriously handicapping or lethal conditions. Antenatal diagnosis has also defined an in utero mortality for some lesions such as diaphragmatic hernia and sacrococcygeal teratoma so that true outcomes can be measured. The limitation of in-utero diagnosis cannot be ignored. The aim of prenatal counselling is to provide information to prospective parents on foetal outcomes, possible interventions, appropriate setting, time and route of delivery and expected postnatal outcomes, immediate and long term.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22142503     DOI: 10.1016/j.earlhumdev.2011.11.004

Source DB:  PubMed          Journal:  Early Hum Dev        ISSN: 0378-3782            Impact factor:   2.079


  4 in total

1.  Impact of fetal counseling on outcome of antenatal congenital surgical anomalies.

Authors:  Shilpa Sharma; Ranjana Bhanot; Dipika Deka; Minu Bajpai; Devendra K Gupta
Journal:  Pediatr Surg Int       Date:  2016-11-18       Impact factor: 1.827

2.  Ascites, anemia and (intestinal) atresia.

Authors:  R M R Tan; J Lee; A Biswas; C Amutha
Journal:  J Perinatol       Date:  2014-01       Impact factor: 2.521

Review 3.  Golden hour of neonatal life: Need of the hour.

Authors:  Deepak Sharma
Journal:  Matern Health Neonatol Perinatol       Date:  2017-09-19

Review 4.  Ethical language and decision-making for prenatally diagnosed lethal malformations.

Authors:  Dominic Wilkinson; Lachlan de Crespigny; Vicki Xafis
Journal:  Semin Fetal Neonatal Med       Date:  2014-09-05       Impact factor: 3.926

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.